149 related articles for article (PubMed ID: 9270574)
1. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.
Ellis CM; Lemmens G; Williams SC; Simmons A; Dawson J; Leigh PN; Chaudhuri KR
Neurology; 1997 Aug; 49(2):438-44. PubMed ID: 9270574
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
[TBL] [Abstract][Full Text] [Related]
3. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study.
Holshouser BA; Komu M; Möller HE; Zijlmans J; Kolem H; Hinshaw DB; Sonninen P; Vermathen P; Heerschap A; Masur H
Magn Reson Med; 1995 May; 33(5):589-94. PubMed ID: 7596261
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
[TBL] [Abstract][Full Text] [Related]
5. Proton MR spectroscopic imaging of the striatum in Parkinson's disease.
Cruz CJ; Aminoff MJ; Meyerhoff DJ; Graham SH; Weiner MW
Magn Reson Imaging; 1997; 15(6):619-24. PubMed ID: 9285801
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
[TBL] [Abstract][Full Text] [Related]
7. A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Taylor-Robinson SD; Turjanski N; Bhattacharya S; Seery JP; Sargentoni J; Brooks DJ; Bryant DJ; Cox IJ
Metab Brain Dis; 1999 Mar; 14(1):45-55. PubMed ID: 10348313
[TBL] [Abstract][Full Text] [Related]
8. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
9. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.
Baik HM; Choe BY; Son BC; Jeun SS; Kim MC; Lee KS; Kim BS; Lee JM; Lee HK; Suh TS
Eur J Radiol; 2003 Sep; 47(3):179-87. PubMed ID: 12927660
[TBL] [Abstract][Full Text] [Related]
10. Proton MR spectroscopy in idiopathic spasmodic torticollis.
Federico F; Lucivero V; Simone IL; Defazio G; De Salvia R; Mezzapesa DM; Petruzzellis M; Tortorella C; Livrea P
Neuroradiology; 2001 Jul; 43(7):532-6. PubMed ID: 11512580
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
Federico F; Simone IL; Lucivero V; Mezzapesa DM; de Mari M; Lamberti P; Petruzzellis M; Ferrari E
Ital J Neurol Sci; 1999 Aug; 20(4):223-9. PubMed ID: 10551908
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
[TBL] [Abstract][Full Text] [Related]
13. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.
Salvan AM; Vion-Dury J; Confort-Gouny S; Nicoli F; Lamoureux S; Cozzone PJ
Invest Radiol; 1997 Aug; 32(8):485-95. PubMed ID: 9258737
[TBL] [Abstract][Full Text] [Related]
15. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy.
Davie CA; Wenning GK; Barker GJ; Tofts PS; Kendall BE; Quinn N; McDonald WI; Marsden CD; Miller DH
Ann Neurol; 1995 Feb; 37(2):204-10. PubMed ID: 7847862
[TBL] [Abstract][Full Text] [Related]
17. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging.
Vermathen P; Laxer KD; Matson GB; Weiner MW
Radiology; 2000 Feb; 214(2):403-10. PubMed ID: 10671587
[TBL] [Abstract][Full Text] [Related]
18. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.
Reneman L; Majoie CB; Flick H; den Heeten GJ
AJNR Am J Neuroradiol; 2002 Feb; 23(2):231-7. PubMed ID: 11847047
[TBL] [Abstract][Full Text] [Related]
19. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
Simmons A; Smail M; Moore E; Williams SC
Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
[TBL] [Abstract][Full Text] [Related]
20. Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.
Choe BY; Park JW; Lee KS; Son BC; Kim MC; Kim BS; Suh TS; Lee HK; Shinn KS
Invest Radiol; 1998 Aug; 33(8):450-5. PubMed ID: 9704284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
